Acadia wins EU approval for DAYBU as first treatment for Rett syndrome

Gilead expands Trodelvy role in first-line metastatic triple-negative breast cancer in Europe

GSK's Jemperli wins FDA priority review for advanced rectal cancer

GSK secures first global approval for Hibsago in Japan

Hanmi Pharm enters exclusive licensing deal with Genentech for obesity therapy HM17321

Rznomics joins Lilly Gateway Labs to accelerate RNA therapeutics

Anbogen Therapeutics enters collaborative research agreement with University of Tokyo for ABT-301 evaluation across multiple tumour types

CureGene commences dosing in Phase I trial of CG-0416

Ipsen completes Kartos Therapeutics acquisition, strengthening late-stage oncology pipeline

Nuvation Bio's safusidenib granted FDA Fast Track Designation for IDH1-mutant glioma treatment

Charles River and Medigen collaborate on next-generation enterovirus vaccine development

Annexin Pharmaceuticals receives proposed INN vanexin for ANXV

Pillar Biosciences, LC-SCRUM-Asia and LSI Medience collaborate for liquid biopsy screening in lung cancer

Arcato reports positive Phase 1 trial results for ARC-001 Gel

Vascarta commences NIH phase I clinical study of VAS-101 in sickle cell disease